Lactose (India) Peer Comparison
BSE: 524202
₹104.10
₹-1.45
(-1.37%)
As on 04-Nov-2026IST
Market cap
₹131 Cr
Revenue (TTM)
₹171 Cr
P/E Ratio
18.9
P/B Ratio
2
Div. Yield
0 %
Edit
| Lactose (India) | Acutaas Chemicals | Piramal Pharma | Wockhardt | Rubicon Research | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
131 | 30,928 | 31,659 | 30,874 | 28,416 |
Revenue (₹ Cr) |
171 | 1,593 | 9,779 | 3,751 | 1,936 |
Net Profit (₹ Cr) |
6.93 | 438.64 | -270.51 | 405.00 | 288.22 |
Net Margin (%) |
4.02 | 27.16 | -2.71 | 10.48 | 14.79 |
RoE (%) |
10.89 | 25.02 | -2.55 | 7.91 | 29.77 |
Price to Earnings |
18.92 | 70.43 | -- | 75.30 | 98.59 |
Price-To-Book |
1.95 | 16.65 | 3.89 | 5.99 | 21.17 |
Income Statement (₹ Cr)
| Lactose (India) | Acutaas Chemicals | Piramal Pharma | Wockhardt | Rubicon Research | |
|---|---|---|---|---|---|
|
Operating Revenue
|
170.68 | 1,592.52 | 9,778.62 | 3,751.00 | 1,935.80 |
|
Total Income
|
172.46 | 1,615.23 | 9,993.26 | 3,863.00 | 1,948.58 |
|
Total Expenditure
|
151.26 | 969.32 | 8,578.44 | 2,984.00 | 1,485.56 |
|
EBITDA
|
19.42 | 623.20 | 1,200.18 | 767.00 | 450.24 |
|
Depreciation
|
6.01 | 41.96 | 887.82 | 228.00 | 50.83 |
|
EBIT
|
13.41 | 581.24 | 312.36 | 539.00 | 399.41 |
|
Interest
|
5.63 | 4.21 | 347.94 | 218.00 | 40.84 |
|
Other Income
|
1.78 | 22.71 | 214.64 | 112.00 | 12.78 |
|
Exceptional Items
|
0.00 | 0.00 | -216.88 | 12.00 | 0.00 |
|
Profit before Tax
|
9.56 | 599.74 | -37.82 | 445.00 | 371.35 |
|
Provision for Tax
|
2.64 | 161.10 | 232.69 | 40.00 | 83.14 |
|
Profit after Tax
|
6.93 | 438.64 | -270.51 | 405.00 | 288.22 |
Liabilities (₹ Cr)
| Lactose (India) | Acutaas Chemicals | Piramal Pharma | Wockhardt | Rubicon Research | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
64.79 | 1,857.45 | 8,142.24 | 5,158.00 | 1,288.82 |
|
Minority Interest
|
0.00 | 0.51 | 0.55 | 5.00 | 0.00 |
|
Non-Current Liabilities
|
28.64 | 47.15 | 5,213.99 | 1,617.00 | 202.03 |
|
Current Liabilities
|
89.80 | 253.37 | 5,158.51 | 1,785.00 | 835.87 |
|
Total Liabilities
|
133.47 | 1,549.26 | 15,513.53 | 8,100.00 | 1,451.43 |
Assets (₹ Cr)
| Lactose (India) | Acutaas Chemicals | Piramal Pharma | Wockhardt | Rubicon Research | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
68.58 | 1,132.12 | 10,687.30 | 5,527.00 | 519.60 |
|
Current Assets
|
98.62 | 1,012.00 | 7,253.65 | 2,764.00 | 1,681.81 |
|
Total Assets
|
133.47 | 1,549.26 | 15,513.53 | 8,100.00 | 1,451.43 |
|
Total Debt*
|
56.22 | 8.18 | 4,720.27 | 1,859.00 | 393.17 |
|
Net Current Assets
|
8.82 | 758.64 | 2,095.14 | 979.00 | 845.94 |
|
Contingent Liabilities
|
7.80 | 15.38 | 99.76 | 770.26 | 12.25 |
Cashflow (₹ Cr)
| Lactose (India) | Acutaas Chemicals | Piramal Pharma | Wockhardt | Rubicon Research | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-0.29 | 118.34 | 892.30 | -22.00 | 159.18 |
|
Cash Flow from Investing Activities
|
-15.57 | -223.94 | -477.46 | -783.00 | -64.81 |
|
Cash from Financing Activities
|
18.81 | 261.12 | -440.83 | 409.00 | -39.81 |
|
Net Cash Inflow / Outflow
|
2.95 | 155.52 | -25.99 | -396.00 | 54.56 |
Ratios
Profitability Ratios
| Lactose (India) | Acutaas Chemicals | Piramal Pharma | Wockhardt | Rubicon Research | |
|---|---|---|---|---|---|
|
ROCE (%)
|
13.01 | 20.14 | 6.61 | 4.07 | 26.97 |
|
ROE (%)
|
10.89 | 25.02 | -2.55 | 7.91 | 29.77 |
|
ROA (%)
|
4.38 | 22.40 | -1.56 | 4.65 | 24.77 |
|
EBIT Margin (%)
|
7.86 | 36.50 | 3.19 | 14.37 | 20.63 |
|
Net Margin (%)
|
4.02 | 27.16 | -2.71 | 10.48 | 14.79 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Lactose (India) | Acutaas Chemicals | Piramal Pharma | Wockhardt | Rubicon Research | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
34.91 | 45.18 | 9.43 | 25.70 | 46.65 |
|
EBIT Growth (%)
|
28.97 | 115.51 | -3.72 | 139.56 | 62.13 |
|
Net Profit Growth (%)
|
57.67 | 95.80 | -199.34 | 894.12 | 89.49 |
|
EPS Growth (%)
|
57.67 | 63.29 | -410.28 | 599.72 | 78.60 |
|
Book Value Growth (%)
|
10.86 | 94.96 | 2.28 | 29.77 | 42.49 |
Valuation Ratios
| Lactose (India) | Acutaas Chemicals | Piramal Pharma | Wockhardt | Rubicon Research | |
|---|---|---|---|---|---|
|
Price / Earnings
|
18.92 | 70.43 | -152.24 | 77.28 | 97.07 |
|
Price / Book Value
|
1.95 | 16.65 | 3.89 | 5.99 | 21.17 |
|
Dividend Yield (%)
|
0.00 | 0.07 | 0.00 | 0.00 | 0.09 |
|
EV/EBITDA
|
9.39 | 49.31 | 29.83 | 42.16 | 62.92 |
|
Market Cap (₹ Cr)
|
111.66 | 19,988.69 | 29,731.27 | 23,064.69 | 0.00 |
Solvency Ratios
| Lactose (India) | Acutaas Chemicals | Piramal Pharma | Wockhardt | Rubicon Research | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.35 | 0.01 | 0.55 | 0.28 | 0.11 |
|
Short term debt to equity ratio
|
0.40 | 0.00 | 0.12 | 0.11 | 0.54 |
|
Current Ratio
|
1.10 | 3.99 | 1.41 | 1.55 | 2.01 |
|
Quick Ratio
|
0.48 | 2.89 | 0.77 | 1.00 | 1.14 |
|
Interest Coverage
|
2.70 | 143.52 | 0.89 | 3.04 | 10.09 |
Operating Efficiency Ratios
| Lactose (India) | Acutaas Chemicals | Piramal Pharma | Wockhardt | Rubicon Research | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
19.60 | 22.50 | 23.05 | 16.85 | 26.28 |
|
Asset Turnover
|
1.08 | 0.81 | 0.56 | 0.43 | 1.66 |
|
Receivable days
|
58.07 | 90.06 | 77.05 | 60.36 | 47.59 |
|
Inventory Days
|
64.83 | 61.02 | 77.13 | 64.42 | 62.58 |
|
Payable days
|
67.48 | 96.06 | 173.49 | 218.94 | 228.78 |
|
Cash Conversion Cycle
|
55.42 | 55.02 | -19.30 | -94.15 | -118.62 |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
